← FDA Drug Approvals (Drugs@FDA)
IBRUTINIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ INC · Approved 2022-03-15
Drug application
- FDA Application #
ANDA211267- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IBRUTINIB
- Generic name
- Ibrutinib
- Active ingredients
- IBRUTINIB
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- SANDOZ INC
- First approval
- 2022-03-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown